Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue

Recruiting now · Not applicable

Conditions studied: Endometrial Neoplasms, Endometrial Cancer Stage I, Sentinel Lymph Node, Metastasis

In brief

This clinical trial evaluates lymph node mapping in newly diagnosed endometrial cancer patients undergoing surgery. The standard technique uses a 2-point methylene blue cervical injection. The study aims to determine if increasing injection points improves mapping success.

Key facts

Study ID
NCT07040657
Run by
Dokuz Eylul University
People needed
100
Starts
2025-05-01
Expected to finish
2026-11-01
Last updated by the study team
2025-06-27

Who can join

Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.